Metabolic syndrome and catheter ablation in atrial fibrillation

Circulation Journal

Volumn 73, Issue 3, 2009, Pages 428-429

  Chinushi, Masaomi ^a   Ito, Masahiro ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETER ABLATION; DISEASE ASSOCIATION; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; METABOLIC SYNDROME X; RECURRENT DISEASE; RISK FACTOR;

ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; METABOLIC SYNDROME X; PREVALENCE; RECURRENCE; RISK FACTORS;

EID: 62649157792     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1134     Document Type: Editorial

References (8)

1. Tang RB, Dong JZ, Liu XP, Long DY, Yu RH, Kalifa J, et al. Metabolic syndrome and risk of recurrence of atrial fbrillation after catheter ablation. Circ J 2009; 73: 438-443.
2. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. A comparison of rate control and rhythm control in patients with atrial fbrillation. N Engl J Med 2002; 347: 1825-1833.
3. Pappone C, Radinovic A, Manguso F, Vicedomini G, Ciconte G, Sacchi S, et al. Atrial fbrillation progression and management: A 5-year prospective follow-up study. Heart Rhythm 2008; 5: 1501-1507.
4. Cha YM, Friedman PA, Asirvatham SJ, Shen WK, Munger TM, Rea RF, et al. Catheter ablation for atrial fbrillation in patients with obesity. Circulation 2008; 117: 2583-2590.
5. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DN, Sasaki S, et al. Metabolic syndrome and risk of development of atrial fbrilla-tion: The Niigata preventive medicine study. Circulation 2008; 117: 1255-1260.
6. Issac TT, Dokainish H, Lakkis NM. Role of infammation in initiation and perpetuation of atrial fbrillation: A systematic review of the publishes data. J Am Coll Cardiol 2007; 50: 2021-2028.
7. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fbrillation. Circulation 1997; 96: 1180-1184.
8. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfnkle M, Yusuf S, et al. Prevention of atrial fbrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis. J Am Coll Cardiol 2005; 45: 1832-1839.